Back to Jane Street Group, LLC Jane Street Group, LLC

BBIOBBIO

Showing 8 of 25 quarters

Position history for Jane Street Group, LLCJane Street Group, LLC's holdings in BridgeBio Pharma, Inc.

Yes. Jane Street Group holds 2,934,193 shares of BBIO (BridgeBio Pharma), worth $218.5M, as of its Q2 2026 13F filing. It increased the position by 1,176,521 shares (+66.9%) from Q1 2026. Jane Street Group has held BBIO since Q2 2020, across 25 quarterly 13F filings.

Current Value

$218.5M

Current Shares

2.9M

Total Value Change

+$205.2M

Total Shares Change

+2.4M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2.9M
+66.9%
$218.5M0.0%$74.48
45
2026-Q1
Increased
1.8M
+414.3%
$130.5M0.0%$74.26
49
2025-Q4
Decreased
341,795
-46.1%
$26.1M0.0%$76.49
0
2025-Q3
Increased
633,886
+25.7%
$32.9M0.0%$51.94
36
2025-Q2
Decreased
504,342
-39.8%
$21.8M0.0%$43.18
0
2025-Q1
Increased
838,358
+26.1%
$29M0.0%$34.57
35
2024-Q4
Increased
664,924
+26.8%
$18.2M0.0%$27.44
35
2024-Q3
Decreased
524,361
-26.9%
$13.4M0.0%$25.46
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used